Value-based healthcare: What’s it worth to you?It takes healthy people to make a healthy society – and that must be taken into account when Share XValue-based healthcare: What’s it worth to you?https://pharmaphorum.com/views-and-analysis/value-based-healthcare-whats-worth/
Beyond patient centricity – supporting the support networkOur new patient-centric world has already gone “beyond the pill”, and now it’s going beyond the patient. There’s a Share XBeyond patient centricity – supporting the support networkhttps://pharmaphorum.com/views-and-analysis/beyond-patient-centricity-support-network/
Start-ups and tech giants are the future of pharma marketingWe are living in a revolutionary time of scientific change and innovation in pharma marketing – and the Share XStart-ups and tech giants are the future of pharma marketinghttps://pharmaphorum.com/sales-marketing/start-ups-and-tech-giants-are-the-future-of-pharma-marketing/
Digital health as a complementary therapyFor years, digital health has been heralded as the saviour of health services and the answer to patient Share XDigital health as a complementary therapyhttps://pharmaphorum.com/digital/digital-health-as-a-complementary-therapy/
Practical tool to address real patient information needsEveryone benefits when patients are informed and empowered – we know that. Adherence rates are higher, services run Share XPractical tool to address real patient information needshttps://pharmaphorum.com/views-analysis-patients/patient-information-needs-practical-tools/
Biosimilar switches and healthcare gainsDespite being used across Europe for more than a decade, biosimilar medications are still something of a mystery Share XBiosimilar switches and healthcare gainshttps://pharmaphorum.com/market-access-2/biosimilar-switches-and-healthcare-gains/
Case study: Ensuring safety by digitally linking prescription management to blood monitoringMonitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care. But Share XCase study: Ensuring safety by digitally linking prescription management to blood monitoringhttps://pharmaphorum.com/views-analysis-digital/ms-case-study-safety-digitally-linking-prescription-management/
Focus on the positive to stop public perception being a barrier to clinical trial participation Public misconceptions surrounding the process, its risks and its benefits remain a significant barrier to clinical trial participation, Share XFocus on the positive to stop public perception being a barrier to clinical trial participation https://pharmaphorum.com/r-d/public-perception-being-barrier-clinical-trial-participation/
AI can save lives, but only if we address data security and usabilityThe UK government pledged in May to use artificial intelligence (AI) to prevent more than 20,000 cancer-related deaths Share XAI can save lives, but only if we address data security and usabilityhttps://pharmaphorum.com/views-and-analysis/ai-can-save-lives-address-data-security/
